Enanta Pharmaceuticals (ENTA): Promising Clinical Stage Biotech With Robust Pipeline
Millennium Management LLC's Strategic Acquisition of Enanta Pharmaceuticals Shares
H.C. Wainwright Maintains Enanta Pharmaceuticals(ENTA.US) With Buy Rating, Maintains Target Price $27
A Glimpse Into The Expert Outlook On Enanta Pharma Through 4 Analysts
Buy Rating for Enanta Pharmaceuticals Amid Reduced Competition and Promising Drug Trials
Enanta Pharmaceuticals (ENTA) Surges 5.6%: Is This an Indication of Further Gains?
Leerink Partners Maintains Enanta Pharmaceuticals(ENTA.US) With Hold Rating
Baird Maintains Enanta Pharmaceuticals(ENTA.US) With Buy Rating, Maintains Target Price $26
Analysts Offer Insights on Healthcare Companies: Enanta Pharmaceuticals (ENTA) and Resmed (RMD)
Enanta Pharmaceuticals (ENTA) Gets a Hold From Leerink Partners
Enanta Pharma Analyst Ratings
JMP Securities Maintains Enanta Pharmaceuticals(ENTA.US) With Buy Rating, Maintains Target Price $22
Enanta Pharmaceuticals Gains Buy Rating on Strong Clinical Results for EDP-323
Enanta Pharmaceuticals Says Phase 2a Trial of Potential RSV Treatment Meets Endpoints
Express News | Enanta Pharmaceuticals Inc: Favorable Safety and Tolerability Observed
Express News | Enanta Pharmaceuticals Inc - Edp-323 Achieves Significant Reductions in Viral Load and Symptoms
Express News | Enanta Pharmaceuticals Announces Positive Topline Results for Edp-323 in a Phase 2a Human Challenge Study of Healthy Adults Infected With Respiratory Syncytial Virus (Rsv)
Enanta Pharmaceuticals Announces Positive Topline Results for EDP-323 in a Phase 2a Human Challenge Study of Healthy Adults Infected With Respiratory Syncytial Virus (RSV)
Enanta Pharmaceuticals to Participate in Investor Conferences in September
Analysts Offer Insights on Healthcare Companies: Enanta Pharmaceuticals (ENTA), Hyperfine (HYPR) and Biogen (BIIB)